| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.00013 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -8.8e-05 | 1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 3.7e-05 | 1 |